Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 3 ( March, 2022 ) > List of Articles

CASE REPORT

Tropical Fever: Unveiling an Asymptomatic Case of Polycythemia Vera

B Kishansing Naik, Sulakshana Sulakshana, Justin Aryabhat Gopaldas, Sai Devvrat

Citation Information : Naik BK, Sulakshana S, Gopaldas JA, Devvrat S. Tropical Fever: Unveiling an Asymptomatic Case of Polycythemia Vera. Indian J Crit Care Med 2022; 26 (3):387-389.

DOI: 10.5005/jp-journals-10071-24137

License: CC BY-NC 4.0

Published Online: 30-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

We report a case of fulminant hepatic failure due to the Budd–Chiari syndrome following preservation with a tropical fever. A young lady came with fever, altered mental status, jaundice, and renal failure. Following tropical workup, it was diagnosed as a case of leptospirosis (WHO Faine's criteria) with multi-organ dysfunction. Despite adequate antimicrobial cover, she progressed to hepatic coma (hyperammonemia) and was noted to have worsening conjugated hyperbilirubinemia. Following history review and evaluation for other causes of hepatic failure, hepatic vein thrombosis was detected in addition to the presence of antibodies against Leptospira antigen. Further studies into the causes of thrombosis and persistent hemoconcentration despite aggressive fluid resuscitation led to the diagnosis of polycythemia vera (cytometric analysis). During her stay, she further worsened despite aggressive organ support including dialysis but she succumbed to gram-negative sepsis that occurred during her stay in ICU. This is an interesting and rare case of leptospirosis that unveiled a case of previously asymptomatic polycythemia vera.


HTML PDF Share
  1. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41(5):1179–1197. DOI: 10.1002/hep.20703.
  2. Roberts EA, Schilsky ML. A practical guideline on Wilson disease. Hepatology 2003;37(6):1475–1492. DOI: 10.1053/jhep.2003.50252.
  3. Noronha Ferreira C, Seijo S, Plessier A, Silva-Junior G, Turon F, Rautou PE, et al. Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis. Hepatology 2016;63(5):1640–1650. DOI: 10.1002/hep.28466.
  4. Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol 2018;37(1):25–30. DOI: 10.1007/s12664-017-0812-y.
  5. Akamatsu N, Sugawara Y, Kokudo N. Budd-Chiari syndrome and liver transplantation. Intractable Rare Dis Res 2015;4(1):24–32. DOI: 10.5582/irdr.2014.01031.
  6. Kumar SS. Indian guidelines for the diagnosis and management of human leptospirosis [Medicine Update, Volume 23, Ch. 7]. APICON; 2013.
  7. Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis 2001;33(11):1834–1841. DOI: 10.1086/324084.
  8. Chávez-Iñiguez JS, Cabrera-Aguilar JS, Garcia-Garcia G, Armendáriz-Borunda J. Acute kidney injury and acute liver failure in Leptospira infection and Weil's Syndrome. J Renal Hepatic Disord 2020;4(2):21–28. DOI: 10.15586/jrenhep.2020.75.
  9. Faucher JF, Chirouze C, Hoen B, Leroy J, Hustache-Mathieu L, Estavoyer JM. Short-course treatment with ceftriaxone for leptospirosis: a retrospective study in a single center in Eastern France. J Infect Chemother 2015;21(3):227–228. DOI: 10.1016/j.jiac.2014.09.002.
  10. Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 2018;8(2):15. DOI: 10.1038/s41408-018-0054-y.
  11. Ageno W, Dentali F, Squizzato A. How I treat splanchnic vein thrombosis. Blood 2014;124(25):3685–3691. DOI: 10.1182/blood-2014-07-551515.
  12. Gianelli U, Iurlo A, Cattaneo D, Bossi A, Cortinovis I, Augello C, et al. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis. Leuk Res 2015;39(5): 525–529. DOI: 10.1016/j.leukres.2015.03.009.
  13. Valla D, Casedevall N, Lacombe C, Varet B, Goldwasser E, Franco D, et al. Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985;103(3):329–334. DOI: 10.7326/0003-4819-103-3-329.
  14. De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: moleculardriven diagnosis and long-term treatment. Thromb Haemost 2016;115(2):240–249. DOI: 10.1160/TH15-04-0326.
  15. Lavu S, Szuber N, Mudireddy M, Yogarajah M, Gangat N, Pardanani A, et al. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: the Mayo clinic experience with 84 consecutive cases. Am J Hematol 2018;93(1):E61–E64. DOI: 10.1002/ajh.24993.
  16. Ahmed S, Irfan O, Siddique S, Abid S. Polycythaemia Vera presenting as a porta hepatis mass. J Ayub Med Coll Abbottabad 2019;31(4): 627–628. PMID: 31933324.
  17. Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int 2018;12(Suppl 1):168–180. DOI: 10.1007/s12072-017-9810-5.
  18. Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, et al; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol 2020;10(5): 477–517. DOI: 10.1016/j.jceh.2020.04.011.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.